Ligand Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.

About LGND

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV.

CEO

Todd Christopher Davis

CEOTodd Christopher Davis

Employees

Employees68

Headquarters

Jupiter, Florida

HeadquartersJupiter, Florida

Founded

1987

Founded1987

Employees

Employees68

LGND Key Statistics

Market cap

2.84B

Market cap2.84B

Price-Earnings ratio

-20.55

Price-Earnings ratio-20.55

Dividend yield

—

Dividend yield—

Average volume

180.00K

Average volume180.00K

High today

$148.79

High today$148.79

Low today

$140.00

Low today$140.00

Open price

$144.80

Open price$144.80

Volume

296.48K

Volume296.48K

52 Week high

$149.21

52 Week high$149.21

52 Week low

$92.04

52 Week low$92.04

LGND News

Seeking Alpha 6h

Ligand raises 2025 revenue and EPS guidance to $225M and $7 amid royalty portfolio momentum

Earnings Call Insights Ligand raises 2025 revenue and EPS guidance to $225M and $7 amid royalty portfolio momentum Aug. 07, 2025 8:02 PM ET Ligand Pharmaceutica...

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own LGND. This list is generated using Robinhood data, and it’s not a recommendation.